LPL Financial
HSTO

LPL Financial’s Histogen Inc. Common Stock HSTO Stock Holding History

LPL Financial’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-88
Closed -$6K – 3450
2019
Q3 		$6K Buy
88
+30
+52% +$1.96K ﹤0.01% 3281
2019
Q2 		$3K Buy
+58
New +$10.1K ﹤0.01% 3274

Other funds holding HSTO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $5.7B AUM 21.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LPL Financial's HSTO Position: Q4 2019 in Review

LPL Financial sold out of Histogen Inc. Common Stock (HSTO) in Q4 2019, closing a stake of 88 shares — an estimated $6K sold.

LPL Financial first reported a position in HSTO in Q2 2019 and held it in 2 quarters. The position peaked at $6K in Q3 2019. 28 funds tracked by Wall St. Rank hold HSTO as of Q4 2019.

  • LPL Financial reported no remaining Histogen Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • LPL Financial sold 88 Histogen Inc. Common Stock shares in Q4 2019, an estimated $6K.
  • LPL Financial first reported a position in Histogen Inc. Common Stock in Q2 2019 and held it in 2 quarters.
  • LPL Financial's Histogen Inc. Common Stock position peaked at $6K in Q3 2019.
  • 28 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2019.

Based on LPL Financial's 13F filing for Q4 2019, filed 14 Feb 2020.